Positioning Statement on the Subject of: Transplantation of Ovarian Tissue
The British Fertility Society (BFS) supports research into cryopreservation on ovarian tissue. This technology provides the potential restoration of fertility for women who have to undergo treatment for cancer or other illnesses that might render them sterile
The BFS, together with the RCOG and HFEA has worked on a consultative document with the aim of providing guidelines for the use of this technology.
Other potential uses for the technique have been suggested, for example, using ovarian tissue as an insurance policy against reproductive ageing. The BFS only supports cryopreservation for young women who would otherwise lose their fertility as a result of treatment for life threatening illnesses, such as cancer. There should be a small number of designated centres in the country to focus on this type of treatment and this work should take place only within the context of research protocols and should not carry a charge.
Notes to Editors
The British Fertility Society is a national organisation and a registered charity. The British Fertility Society currently has over 800 members comprising clinicians, nurses, scientists, counsellors and members from patients support groups and is aimed at representing the community of professionals who look after couples with infertility. The British Fertility Society also runs regular educational meetings and supports educational awards for research into infertility.